Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease

Benzon Dy, Carol A. Reynolds, Dietlind L. Wahner-Roedler, Judy C Boughey

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There are few reports confirming the validity of sentinel lymph biopsy in patients with a background of lymphoproliferative disease. We reviewed nine cases of women who underwent sentinel lymph node (SLN) surgery for staging of primary breast cancer with a diagnosis of lymphoproliferative disease. SLN identification rate was 100 per cent with a background of lymphoma in the sentinel node in eight of the nine patients.With a mean follow-up of 37 months, there have been no axillary recurrences in any of these patients. These cases illustrate that SLN staging is feasible and provides axillary staging information in women with breast cancer despiteb synchronous lymphoproliferative disease.

Original languageEnglish (US)
Pages (from-to)1423-1425
Number of pages3
JournalAmerican Surgeon
Volume76
Issue number12
StatePublished - Dec 2010

Fingerprint

Breast Neoplasms
Lymph
Lymphoma
Biopsy
Recurrence
Sentinel Lymph Node
cyhalothrin

ASJC Scopus subject areas

  • Surgery

Cite this

Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease. / Dy, Benzon; Reynolds, Carol A.; Wahner-Roedler, Dietlind L.; Boughey, Judy C.

In: American Surgeon, Vol. 76, No. 12, 12.2010, p. 1423-1425.

Research output: Contribution to journalArticle

Dy, Benzon ; Reynolds, Carol A. ; Wahner-Roedler, Dietlind L. ; Boughey, Judy C. / Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease. In: American Surgeon. 2010 ; Vol. 76, No. 12. pp. 1423-1425.
@article{95f7331fc0504f7c8436d1c620fad5cc,
title = "Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease",
abstract = "There are few reports confirming the validity of sentinel lymph biopsy in patients with a background of lymphoproliferative disease. We reviewed nine cases of women who underwent sentinel lymph node (SLN) surgery for staging of primary breast cancer with a diagnosis of lymphoproliferative disease. SLN identification rate was 100 per cent with a background of lymphoma in the sentinel node in eight of the nine patients.With a mean follow-up of 37 months, there have been no axillary recurrences in any of these patients. These cases illustrate that SLN staging is feasible and provides axillary staging information in women with breast cancer despiteb synchronous lymphoproliferative disease.",
author = "Benzon Dy and Reynolds, {Carol A.} and Wahner-Roedler, {Dietlind L.} and Boughey, {Judy C}",
year = "2010",
month = "12",
language = "English (US)",
volume = "76",
pages = "1423--1425",
journal = "The American surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "12",

}

TY - JOUR

T1 - Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease

AU - Dy, Benzon

AU - Reynolds, Carol A.

AU - Wahner-Roedler, Dietlind L.

AU - Boughey, Judy C

PY - 2010/12

Y1 - 2010/12

N2 - There are few reports confirming the validity of sentinel lymph biopsy in patients with a background of lymphoproliferative disease. We reviewed nine cases of women who underwent sentinel lymph node (SLN) surgery for staging of primary breast cancer with a diagnosis of lymphoproliferative disease. SLN identification rate was 100 per cent with a background of lymphoma in the sentinel node in eight of the nine patients.With a mean follow-up of 37 months, there have been no axillary recurrences in any of these patients. These cases illustrate that SLN staging is feasible and provides axillary staging information in women with breast cancer despiteb synchronous lymphoproliferative disease.

AB - There are few reports confirming the validity of sentinel lymph biopsy in patients with a background of lymphoproliferative disease. We reviewed nine cases of women who underwent sentinel lymph node (SLN) surgery for staging of primary breast cancer with a diagnosis of lymphoproliferative disease. SLN identification rate was 100 per cent with a background of lymphoma in the sentinel node in eight of the nine patients.With a mean follow-up of 37 months, there have been no axillary recurrences in any of these patients. These cases illustrate that SLN staging is feasible and provides axillary staging information in women with breast cancer despiteb synchronous lymphoproliferative disease.

UR - http://www.scopus.com/inward/record.url?scp=78651365246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651365246&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 1423

EP - 1425

JO - The American surgeon

JF - The American surgeon

SN - 0003-1348

IS - 12

ER -